Fluge, Ø., Bruland, O., Risa, K., Storstein, A., Kristoffersen, E.K., Sapkota, D., Næss, H., Dahl, O., Nyland, H. and Mella, O. (2011) Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study. PLOS ONE, 6, Article ID: e26358.
https://doi.org/10.1371/journal.pone.0026358

has been cited by the following article:

• TITLE: When a 17-Year-Old Girl Is Diagnosed with Myalgic Encephalomyelitis: A Case Study from the Swedish Health Care System—A Parent Perspective

  AUTHORS: Eva Bojner Horwitz, Jonas Axelsson, Olli Polo, Leif Widebert, Töres Theorell, Anabelle Paulino, David Ullman, Jonas Bergquist

  KEYWORDS: Case Study, Myalgic Encephalomyelitis, Parent Perspective, Swedish Health Care

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.11 No.8, August 4, 2022

  ABSTRACT: This case study presents different strategies that were explored by the patient’s mother (who is a researcher in music and medicine) when her 17-year-old daughter was diagnosed with ME (Myalgic Encephalomyelitis), also known as Chronic Fatigue Syndrome (CFS). ME is not widely recognized in the Global as well as the Swedish population at large, and within healthcare, there are no standardized recommended treatments, partly due to the lack of published evidence-based studies. This case study aims to provide insights into how the Swedish healthcare system works, how different clinics and hospitals within it operate and interconnect; and how these contribute to health outcomes after 15 months of treatment.